Allergan, Inc. (AGN) Bid Could Come In Just Above $45B

April 21, 2014 5:16 PM EDT Send to a Friend

CNBC's David Faber reports that Valeant Pharmaceuticals' (NYSE: VRX) bid ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Allergan, Inc. (AGN) Bid Could Come In Just Above $45B

Member Login

Free News Feed